Literature DB >> 20019195

Aberrant inflammatory response to Streptococcus pyogenes in mice lacking myeloid differentiation factor 88.

Torsten G Loof1, Oliver Goldmann, André Gessner, Heiko Herwald, Eva Medina.   

Abstract

Several in vitro studies have emphasized the importance of toll-like receptor/myeloid differentiation factor 88 (MyD88) signaling in the inflammatory response to Streptococcus pyogenes. Since the extent of inflammation has been implicated in the severity of streptococcal diseases, we have examined here the role of toll-like receptor/MyD88 signaling in the pathophysiology of experimental S. pyogenes infection. To this end, we compared the response of MyD88-knockout (MyD88(-/-)) after subcutaneous inoculation with S. pyogenes with that of C57BL/6 mice. Our results show that MyD88(-/-) mice harbored significantly more bacteria in the organs and succumbed to infection much earlier than C57BL/6 animals. Absence of MyD88 resulted in diminished production of inflammatory cytokines such as interleukin-12, interferon-gamma, and tumor necrosis factor-alpha as well as chemoattractants such as monocyte chemotactic protein-1 (MCP-1) and Keratinocyte-derived chemokine (KC), and hampered recruitment of effector cells involved in bacterial clearance (macrophages and neutrophils) to the infection site. Furthermore, MyD88(-/-) but not C57BL/6 mice exhibited a massive infiltration of eosinophils in infected organs, which can be explained by an impaired production of the regulatory chemokines, gamma interferon-induced monokine (MIG/CXCL9) and interferon-induced protein 10 (IP-10/CXCL10), which can inhibit transmigration of eosinophils. Our results indicate that MyD88 signaling targets effector cells to the site of streptococcal infection and prevents extravasation of cells that can induce tissue damage. Therefore, MyD88 signaling may be important for shaping the quality of the inflammatory response elicited during infection to ensure optimal effector functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019195      PMCID: PMC2808082          DOI: 10.2353/ajpath.2010.090422

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Unresponsiveness of MyD88-deficient mice to endotoxin.

Authors:  T Kawai; O Adachi; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

2.  Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice.

Authors:  Barbara Albiger; Andreas Sandgren; Hiroaki Katsuragi; Ulf Meyer-Hoffert; Katharina Beiter; Florian Wartha; Mathias Hornef; Staffan Normark; Birgitta Henriques Normark
Journal:  Cell Microbiol       Date:  2005-11       Impact factor: 3.715

3.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

4.  Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis.

Authors:  S Horie; Y Okubo; M Hossain; E Sato; H Nomura; S Koyama; J Suzuki; M Isobe; M Sekiguchi
Journal:  Intern Med       Date:  1997-03       Impact factor: 1.271

Review 5.  The role of adhesion molecules in human eosinophil and basophil recruitment.

Authors:  B S Bochner; R P Schleimer
Journal:  J Allergy Clin Immunol       Date:  1994-09       Impact factor: 10.793

6.  CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism.

Authors:  Patricia C Fulkerson; Hongyan Zhu; David A Williams; Nives Zimmermann; Marc E Rothenberg
Journal:  Blood       Date:  2005-03-31       Impact factor: 22.113

7.  Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production.

Authors:  Hongyan Diao; Masashi Kohanawa
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 8.  Chemokines and allergic disease.

Authors:  R Nickel; L A Beck; C Stellato; R P Schleimer
Journal:  J Allergy Clin Immunol       Date:  1999-10       Impact factor: 10.793

9.  Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus.

Authors:  Shawn J Skerrett; H Denny Liggitt; Adeline M Hajjar; Christopher B Wilson
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

10.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

Authors:  O Adachi; T Kawai; K Takeda; M Matsumoto; H Tsutsui; M Sakagami; K Nakanishi; S Akira
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

View more
  20 in total

1.  Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice.

Authors:  Sanjay Batra; Shanshan Cai; Gayathriy Balamayooran; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

2.  TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages.

Authors:  Christian P Bauerfeld; Ruchi Rastogi; Gaila Pirockinaite; Icksoo Lee; Maik Hüttemann; Bobby Monks; Morris J Birnbaum; Luigi Franchi; Gabriel Nuñez; Lobelia Samavati
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

3.  Importance of Toll-like receptor 9 in host defense against M1T1 group A Streptococcus infections.

Authors:  Annelies S Zinkernagel; Petr Hruz; Satoshi Uchiyama; Maren von Köckritz-Blickwede; Reto A Schuepbach; Tomoko Hayashi; Dennis A Carson; Victor Nizet
Journal:  J Innate Immun       Date:  2011-08-19       Impact factor: 7.349

Review 4.  Group A Streptococcus encounters with host macrophages.

Authors:  J Andrés Valderrama; Victor Nizet
Journal:  Future Microbiol       Date:  2017-12-11       Impact factor: 3.165

5.  Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection.

Authors:  Nina Gratz; Harald Hartweger; Ulrich Matt; Franz Kratochvill; Marton Janos; Stefanie Sigel; Barbara Drobits; Xiao-Dong Li; Sylvia Knapp; Pavel Kovarik
Journal:  PLoS Pathog       Date:  2011-05-19       Impact factor: 6.823

6.  Lipoteichoic acid anchor triggers Mincle to drive protective immunity against invasive group A Streptococcus infection.

Authors:  Takashi Imai; Takayuki Matsumura; Sabine Mayer-Lambertz; Christine A Wells; Eri Ishikawa; Suzanne K Butcher; Timothy C Barnett; Mark J Walker; Akihiro Imamura; Hideharu Ishida; Tadayoshi Ikebe; Tomofumi Miyamoto; Manabu Ato; Shouichi Ohga; Bernd Lepenies; Nina M van Sorge; Sho Yamasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-23       Impact factor: 11.205

7.  Colonization of the Murine Oropharynx by Streptococcus pyogenes Is Governed by the Rgg2/3 Quorum Sensing System.

Authors:  Artemis Gogos; Michael J Federle
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

8.  Dextromethorphan Attenuates NADPH Oxidase-Regulated Glycogen Synthase Kinase 3β and NF-κB Activation and Reduces Nitric Oxide Production in Group A Streptococcal Infection.

Authors:  Chia-Ling Chen; Miao-Huei Cheng; Chih-Feng Kuo; Yi-Lin Cheng; Ming-Han Li; Chih-Peng Chang; Jiunn-Jong Wu; Robert Anderson; Shuying Wang; Pei-Jane Tsai; Ching-Chuan Liu; Yee-Shin Lin
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

9.  Association of matrix metalloproteinase 3 and endogenous inhibitors with inflammatory markers in mitral valve disease and calcification.

Authors:  Sonia Aloui; Wiem Zidi; Sana Ouali; Imen Guizani; Sameh Hadj-Taieb; Mohamed Sami Mourali; Moncef Feki; Monia Allal-Elasmi
Journal:  Mol Biol Rep       Date:  2018-10-09       Impact factor: 2.316

10.  A Streptococcus Quorum Sensing System Enables Suppression of Innate Immunity.

Authors:  Kate M Rahbari; Jennifer C Chang; Michael J Federle
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.